1. Home
  2. SGMO vs CLAR Comparison

SGMO vs CLAR Comparison

Compare SGMO & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMO
  • CLAR
  • Stock Information
  • Founded
  • SGMO 1995
  • CLAR 1957
  • Country
  • SGMO United States
  • CLAR United States
  • Employees
  • SGMO N/A
  • CLAR N/A
  • Industry
  • SGMO Biotechnology: Biological Products (No Diagnostic Substances)
  • CLAR Recreational Games/Products/Toys
  • Sector
  • SGMO Health Care
  • CLAR Consumer Discretionary
  • Exchange
  • SGMO Nasdaq
  • CLAR Nasdaq
  • Market Cap
  • SGMO 122.8M
  • CLAR 123.3M
  • IPO Year
  • SGMO 2000
  • CLAR N/A
  • Fundamental
  • Price
  • SGMO $0.64
  • CLAR $3.51
  • Analyst Decision
  • SGMO Strong Buy
  • CLAR Strong Buy
  • Analyst Count
  • SGMO 7
  • CLAR 3
  • Target Price
  • SGMO $5.29
  • CLAR $5.33
  • AVG Volume (30 Days)
  • SGMO 4.9M
  • CLAR 157.5K
  • Earning Date
  • SGMO 11-11-2025
  • CLAR 11-06-2025
  • Dividend Yield
  • SGMO N/A
  • CLAR 2.86%
  • EPS Growth
  • SGMO N/A
  • CLAR N/A
  • EPS
  • SGMO N/A
  • CLAR N/A
  • Revenue
  • SGMO $81,706,000.00
  • CLAR $254,200,000.00
  • Revenue This Year
  • SGMO $28.47
  • CLAR N/A
  • Revenue Next Year
  • SGMO N/A
  • CLAR $4.38
  • P/E Ratio
  • SGMO N/A
  • CLAR N/A
  • Revenue Growth
  • SGMO 565.52
  • CLAR N/A
  • 52 Week Low
  • SGMO $0.41
  • CLAR $3.02
  • 52 Week High
  • SGMO $3.18
  • CLAR $5.29
  • Technical
  • Relative Strength Index (RSI)
  • SGMO 49.82
  • CLAR 50.53
  • Support Level
  • SGMO $0.62
  • CLAR $3.08
  • Resistance Level
  • SGMO $0.69
  • CLAR $3.46
  • Average True Range (ATR)
  • SGMO 0.05
  • CLAR 0.15
  • MACD
  • SGMO -0.01
  • CLAR 0.02
  • Stochastic Oscillator
  • SGMO 25.77
  • CLAR 93.42

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

Share on Social Networks: